|
|
Volumn 334, Issue 1, 1996, Pages 50-51
|
|
New therapy for ovarian cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
CYCLOPHOSPHAMIDE;
MELPHALAN;
PACLITAXEL;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CANCER STAGING;
CAUSE OF DEATH;
CLINICAL TRIAL;
EDITORIAL;
HUMAN;
META ANALYSIS;
OVARY CANCER;
PHASE 2 CLINICAL TRIAL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CYCLOPHOSPHAMIDE;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
SURVIVAL RATE;
|
|
EID: 0030042665
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199601043340112 Document Type: Editorial |
|
Times cited : (39)
|
|
References (0)
|
